Top movers in Tuesday's session
By Mill Chart
Last update: Apr 9, 2024
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Today's top gainers
| Ticker | Change | Comment |
|---|---|---|
| ALLR | 2.0K% | Exciting news for ALLARITY THERAPEUTICS INC (NASDAQ:ALLR) as its stock price surged 2.0K% to $4.46 during Tuesday's session. The stock is trading 46.37% lower than a month ago. |
| LASE | 100.0% | LASER PHOTONICS CORP (NASDAQ:LASE) experienced a significant 100.0% increase, reaching $2.86 during Tuesday's session. A press release (Laser Photonics Secures Order From L3Harris Technologies for LaserTower Marking & Engraving System) was released earlier today. |
| MGAM | 98.0% | MOBILE GLOBAL ESPORTS INC's (NASDAQ:MGAM) shares rose 98.0% to $0.24. In the last month the share price dropped with 42.42%. |
| SLNA | 75.75% | SELINA HOSPITALITY PLC (NASDAQ:SLNA) experienced a significant 75.75% increase, reaching $0.07 during Tuesday's session. In the last month the stock lost 84.13%. |
| MDIA | 59.9% | MEDIACO HOLDING INC-CL A's (NASDAQ:MDIA) shares soared 59.9% to $4.83 during Tuesday's session. In the last month the share price increased with 491.0%. |
| CNXA | 44.95% | Investors witnessed a remarkable 44.95% rise in CONNEXA SPORTS TECHNOLOGIES's (NASDAQ:CNXA) shares, which climbed to $0.58 during Tuesday's session. In the last month the share price increased with 68.08%. |
| GPAK | 33.39% | GAMER PAKISTAN INC's (NASDAQ:GPAK) stock price is advancing with 33.39% to a price of $0.29. Shareholders saw the stock price going 35.16% lower in the past 3 months. |
| BSGM | 30.65% | With a 30.65% surge, BIOSIG TECHNOLOGIES INC's (NASDAQ:BSGM) stock price reached $1.62 during Tuesday's session, signaling positive momentum. Shareholders saw the stock price going 100.0% higher in the past month. |
| SYRS | 28.44% | SYROS PHARMACEUTICALS INC's (NASDAQ:SYRS) stock price increased by 28.44% to $5.78. A press release (Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression) was released earlier today. |
| IZM | 25.0% | ICZOOM GROUP INC -CLASS A's (NASDAQ:IZM) shares rose 25.0% to $29.0 during Tuesday's session. The stock is trading 151.0% higher than a month ago. |
For the full top gainers list go to our top gainers page.
Today's top losers
| Ticker | Change | Comment |
|---|---|---|
| VINC | -74.47% | VINCERX PHARMA INC's (NASDAQ:VINC) stock price encountered a 74.47% decline, reaching $1.22 during Tuesday's session. In the last month the share price dropped with 39.65%. |
| WAVE | -33.33% | Investors witnessed a 33.33% drop in ECO WAVE POWER GLOBAL AB-ADR's (NASDAQ:WAVE) stock price, which closed at $2.8 during Tuesday's session. In the last month the share price increased with 213.0%. |
| AZTR | -21.67% | Investors witnessed a 21.67% decrease in AZITRA INC's (NYSEARCA:AZTR) stock price, which closed at $0.17 during Tuesday's session. In the last 3 months the stock lost 81.5%. |
| HUBC | -21.64% | HUB CYBER SECURITY LTD's (NASDAQ:HUBC) stock price decreased by 21.64% to $1.05. Shareholders saw the stock price going 27.57% lower in the past 3 months. |
| WGSWW | -20.21% | GENEDX HOLDINGS CORP (NASDAQ:WGSWW) encountered a 20.21% decrease in its shares, reaching $0.03 during Tuesday's session. In the last month the stock lost 59.4%. |
| TLRY | -19.88% | The market experienced a downward movement in TILRAY BRANDS INC's (NASDAQ:TLRY) stock price, closing at $2.08 with a 19.88% decrease during Tuesday's session. The company's earnings where released Yesterday. Earlier today the company had a press release: Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results. |
| KA | -19.24% | KINETA INC's (NASDAQ:KA) shares fell 19.24% to $0.44 during Tuesday's session. Shareholders saw the stock price going 22.3% lower in the past month. |
| FCUV | -17.91% | Investors witnessed a 17.91% drop in FOCUS UNIVERSAL INC's (NASDAQ:FCUV) stock price, which closed at $0.29 during Tuesday's session. In the last 3 months the stock lost 76.69%. |
| CVKD | -16.96% | CADRENAL THERAPEUTICS INC (NASDAQ:CVKD) encountered a 16.96% decrease in its shares, reaching $0.42 during Tuesday's session. In the last month the stock lost 23.84%. |
| VVPR | -16.25% | The market experienced a 16.25% downturn in VIVOPOWER INTERNATIONAL PLC's (NASDAQ:VVPR) stock price, closing at $4.69 during Tuesday's session. A press release (VIVOPOWER ANNOUNCES FURTHER STRATEGIC DIRECT INVESTMENT IN TEMBO FROM EMIRATI INVESTMENT OFFICE) was released yesterday. |
To see the full list of top losers you can use our top losers page.
SYROS PHARMACEUTICALS INC
NASDAQ:SYRS (4/29/2024, 7:00:01 PM)
After market: 5.14 -0.24 (-4.46%)5.38
+0.34 (+6.75%)
SYRS News
21 days ago - ChartmillWhat's going on in today's sessionWondering how the US markets performed one hour before the close of the markets on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
21 days ago - ChartmillTop movers in Tuesday's sessionHere are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
21 days ago - Syros PharmaceuticalsSyros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
a month ago - Syros PharmaceuticalsSyros Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
a month ago - InvestorPlaceSYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023SYRS stock results show that Syros Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
a month ago - BusinessInsiderSYRS Stock Earnings: Syros Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips Syros Pharmaceuticals (NASDAQ:SYRS) just reported results for the fourth quarte...
a month ago - Syros PharmaceuticalsSyros Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
a month ago - Syros PharmaceuticalsSyros Announces Completion of Enrollment of 190 Patients Necessary to Support Primary Endpoint Analysis in SELECT-MDS-1 Phase 3 Trial
a month ago - Syros PharmaceuticalsSyros to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, March 27, 20242 months ago - Market News VideoSyros Pharmaceuticals Becomes Oversold (SYRS)
2 months ago - Syros PharmaceuticalsSyros to Participate in TD Cowen 44th Annual Health Care Conference
3 months ago - InvestorPlace3 Once-in-a-Lifetime Penny Stocks With Unprecedented Surge PotentialIs your portfolio is in dire need of making new all-time highs? A new economic cycle is to send these penny stocks with potential up.
